NEW YORK – Novartis' key patent on its radioligand therapy Lutathera (lutetium Lu 177 dotatate) isn't set to expire until 2038, but radiopharmaceutical company Lantheus is already preparing to ...
A U.S. appeals court on Wednesday overturned a $481 million ruling that New York's Columbia University had won against ​software company Gen Digital for infringing patents related to ‌cybersecurity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results